Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aliza Thompson

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|April 13, 2023
Overcoming Barriers to Drug Development in Children with CKDMona Khurana, Gunter F Egger, Lynne Yao, et al.
Kidney Medicine|April 4, 2022
Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney DiseasesKelli Collins Damron, Robert Friedman, Lesley A Inker, et al.
Circulation|January 7, 2021
Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical TrialsRavi B Patel, Jozine M Ter Maaten, João Pedro Ferreira, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2020
End Points for Clinical Trials in Primary HyperoxaluriaDawn S Milliner, Tracy L McGregor, Aliza Thompson, et al.
Annals of Internal Medicine|November 18, 2024
The Effect of Denosumab on Risk for Emergently Treated Hypocalcemia by Stage of Chronic Kidney Disease : A Target Trial EmulationSteven T Bird, Kate Gelperin, Elizabeth R Smith, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 21, 2023
End Point Considerations for Clinical Trials in Enteric HyperoxaluriaCraig B Langman, Dean Assimos, Melanie Blank, et al.
JAMA|January 19, 2024
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent PatientsSteven T Bird, Elizabeth R Smith, Kate Gelperin, et al.
Pediatric Research|August 31, 2017
Enhancing clinical trial development for pediatric kidney diseasesH William Schnaper, Joseph T Flynn, Coleman Gross, et al.
International Journal of Cardiology|May 4, 2016
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approvalFaiez Zannad, Patrick Rossignol, Wendy Gattis Stough, et al.
JAMA Internal Medicine|October 25, 2016
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service MedicareCunlin Wang, Robert Kane, Mark Levenson, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Journal of the American Society of Nephrology : CJASN|April 13, 2023
Overcoming Barriers to Drug Development in Children with CKDMona Khurana, Gunter F Egger, Lynne Yao, et al.
Kidney Medicine|April 4, 2022
Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney DiseasesKelli Collins Damron, Robert Friedman, Lesley A Inker, et al.
Circulation|January 7, 2021
Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical TrialsRavi B Patel, Jozine M Ter Maaten, João Pedro Ferreira, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2020
End Points for Clinical Trials in Primary HyperoxaluriaDawn S Milliner, Tracy L McGregor, Aliza Thompson, et al.
Annals of Internal Medicine|November 18, 2024
The Effect of Denosumab on Risk for Emergently Treated Hypocalcemia by Stage of Chronic Kidney Disease : A Target Trial EmulationSteven T Bird, Kate Gelperin, Elizabeth R Smith, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 21, 2023
End Point Considerations for Clinical Trials in Enteric HyperoxaluriaCraig B Langman, Dean Assimos, Melanie Blank, et al.
JAMA|January 19, 2024
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent PatientsSteven T Bird, Elizabeth R Smith, Kate Gelperin, et al.
Pediatric Research|August 31, 2017
Enhancing clinical trial development for pediatric kidney diseasesH William Schnaper, Joseph T Flynn, Coleman Gross, et al.
International Journal of Cardiology|May 4, 2016
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approvalFaiez Zannad, Patrick Rossignol, Wendy Gattis Stough, et al.
JAMA Internal Medicine|October 25, 2016
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service MedicareCunlin Wang, Robert Kane, Mark Levenson, et al.
Pageof 3